Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.01417
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2017
Authors
Publisher
Frontiers Media SA